FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065957015> ?p ?o ?g. }

• W2065957015 endingPage "509" @default.
• W2065957015 startingPage "504" @default.
• W2065957015 abstract "This 10-week study was conducted to determine the pharmacokinetics of varying doses of agalsidase alfa and evaluate the effect of dose and dosing frequency on plasma Gb3 levels.Eighteen adult male Fabry patients, naive to enzyme replacement therapy, were randomized to one of five regimens: 0.1, 0.2, or 0.4 mg/kg weekly; 0.2 mg/kg every other week (the approved dose); or 0.4 mg/kg every other week. Intravenous infusion rate was 0.1 mg/kg per 20 minutes. Plasma Gb3 levels were assessed at baseline and periodically during the study.The mean half-life was 56-76 minutes, and the mean volume of distribution at steady state was 17%-18% of body weight, with no significant association between dose and half-life, clearance, or volume of distribution at steady state. The area under the curve was linearly proportional to the dose from 0.1 to 0.4 mg/kg. Baseline average plasma Gb3 was 9.12 +/- 2.61 nmol/mL and after 10 weeks of treatment was significantly reduced by about 50% in each group with no statistically significant differences between groups.Reduction of plasma Gb3 levels was independent of dose or dose frequency in the range tested. These observations, coupled with the clinical trial experience of both agalsidase alfa and agalsidase beta, indicate that the standard dose of agalsidase alfa is sufficient to maximally reduce plasma Gb3. However, because plasma Gb3 is not a validated surrogate of disease severity in Fabry disease, further clinical study will be required to determine the optimal dosing regimen for providing maximal clinical benefit." @default.
• W2065957015 created "2016-06-24" @default.
• W2065957015 creator A5001000588 @default.
• W2065957015 creator A5001052872 @default.
• W2065957015 creator A5026413952 @default.
• W2065957015 creator A5068505292 @default.
• W2065957015 date "2007-08-01" @default.
• W2065957015 modified "2023-09-30" @default.
• W2065957015 title "The pharmacology of multiple regimens of agalsidase alfa enzyme replacement therapy for Fabry disease" @default.
• W2065957015 cites W1490194415 @default.
• W2065957015 cites W1530794397 @default.
• W2065957015 cites W1534234912 @default.
• W2065957015 cites W1790440725 @default.
• W2065957015 cites W1964164302 @default.
• W2065957015 cites W1965714350 @default.
• W2065957015 cites W1968427188 @default.
• W2065957015 cites W1969328459 @default.
• W2065957015 cites W1975365119 @default.
• W2065957015 cites W1979235258 @default.
• W2065957015 cites W1980743876 @default.
• W2065957015 cites W1997278734 @default.
• W2065957015 cites W2022356406 @default.
• W2065957015 cites W2023001129 @default.
• W2065957015 cites W2026507072 @default.
• W2065957015 cites W2039770589 @default.
• W2065957015 cites W2042609729 @default.
• W2065957015 cites W2046891919 @default.
• W2065957015 cites W2052866791 @default.
• W2065957015 cites W2077459222 @default.
• W2065957015 cites W2078579961 @default.
• W2065957015 cites W2079324568 @default.
• W2065957015 cites W2084201369 @default.
• W2065957015 cites W2093722439 @default.
• W2065957015 cites W2094557474 @default.
• W2065957015 cites W2099728000 @default.
• W2065957015 cites W2125879510 @default.
• W2065957015 cites W2133130909 @default.
• W2065957015 cites W2136689144 @default.
• W2065957015 cites W2143322674 @default.
• W2065957015 cites W2149357832 @default.
• W2065957015 cites W2150885355 @default.
• W2065957015 cites W2152061175 @default.
• W2065957015 cites W2160213856 @default.
• W2065957015 cites W2163146708 @default.
• W2065957015 cites W2165705941 @default.
• W2065957015 cites W2166030075 @default.
• W2065957015 cites W2166798370 @default.
• W2065957015 cites W2313827278 @default.
• W2065957015 cites W2332862830 @default.
• W2065957015 cites W3150370576 @default.
• W2065957015 doi "https://doi.org/10.1097/gim.0b013e318133fb1b" @default.
• W2065957015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17700388" @default.
• W2065957015 hasPublicationYear "2007" @default.
• W2065957015 type Work @default.
• W2065957015 sameAs 2065957015 @default.
• W2065957015 citedByCount "40" @default.
• W2065957015 countsByYear W20659570152012 @default.
• W2065957015 countsByYear W20659570152013 @default.
• W2065957015 countsByYear W20659570152014 @default.
• W2065957015 countsByYear W20659570152015 @default.
• W2065957015 countsByYear W20659570152016 @default.
• W2065957015 countsByYear W20659570152017 @default.
• W2065957015 countsByYear W20659570152018 @default.
• W2065957015 countsByYear W20659570152019 @default.
• W2065957015 countsByYear W20659570152020 @default.
• W2065957015 countsByYear W20659570152021 @default.
• W2065957015 countsByYear W20659570152023 @default.
• W2065957015 crossrefType "journal-article" @default.
• W2065957015 hasAuthorship W2065957015A5001000588 @default.
• W2065957015 hasAuthorship W2065957015A5001052872 @default.
• W2065957015 hasAuthorship W2065957015A5026413952 @default.
• W2065957015 hasAuthorship W2065957015A5068505292 @default.
• W2065957015 hasBestOaLocation W20659570151 @default.
• W2065957015 hasConcept C112705442 @default.
• W2065957015 hasConcept C126322002 @default.
• W2065957015 hasConcept C126894567 @default.
• W2065957015 hasConcept C139254425 @default.
• W2065957015 hasConcept C2777288759 @default.
• W2065957015 hasConcept C2777404818 @default.
• W2065957015 hasConcept C2779134260 @default.
• W2065957015 hasConcept C2779969927 @default.
• W2065957015 hasConcept C3018403923 @default.
• W2065957015 hasConcept C71924100 @default.
• W2065957015 hasConcept C98274493 @default.
• W2065957015 hasConceptScore W2065957015C112705442 @default.
• W2065957015 hasConceptScore W2065957015C126322002 @default.
• W2065957015 hasConceptScore W2065957015C126894567 @default.
• W2065957015 hasConceptScore W2065957015C139254425 @default.
• W2065957015 hasConceptScore W2065957015C2777288759 @default.
• W2065957015 hasConceptScore W2065957015C2777404818 @default.
• W2065957015 hasConceptScore W2065957015C2779134260 @default.
• W2065957015 hasConceptScore W2065957015C2779969927 @default.
• W2065957015 hasConceptScore W2065957015C3018403923 @default.
• W2065957015 hasConceptScore W2065957015C71924100 @default.
• W2065957015 hasConceptScore W2065957015C98274493 @default.
• W2065957015 hasIssue "8" @default.
• W2065957015 hasLocation W20659570151 @default.
• W2065957015 hasLocation W20659570152 @default.

• next